Back to results
US 2026/0076958 A1Published application
Liquid formulations of indacaterol
AssigneeAerorx Therapeutics LLC
InventorsJohn CHAN, Keith Try UNG, Mei-Chang KUO, John Nigel PRITCHARD
Life of this patent
Estimating the term…
Abstract
Aqueous formulations of indacaterol are disclosed. The formulations may find use in the treatment of respiratory disorders, inflammatory disorders, or obstructive airway diseases. Methods of using the formulations and kits comprising the formulations are also encompassed by the disclosure.
Claims21
1-20. (canceled)
An aqueous pharmaceutical composition comprising:
- from about 20 weight percent to 99.9 weight percent water;
- indacaterol, or a pharmaceutically acceptable salt thereof, present at a concentration of 10 μg/mL to 2 mg/mL;
- glycopyrrolate, or a pharmaceutically acceptable salt thereof, present at a concentration of about 10 μg/mL to 2 mg/mL,
- two or more tonicity modifiers;
- and
- a buffer,
- wherein the indacaterol is present as a free base or as a pharmaceutically acceptable salt thereof without the presence of maleic acid from a maleate salt in the aqueous pharmaceutical composition, and
- wherein the aqueous pharmaceutical composition has a pH from 3 to 5.
5 more elements
Dependencies are inferred from the claim text.